ClinicalTrialsFinder

Refractory Head and Neck Squamous Cell Carcinoma Clinical Trials in Ann Arbor, Michigan

1 recruitingAnn Arbor, Michigan

Showing 1–1 of 1 trials

Recruiting
Phase 3

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Metastatic Head and Neck Squamous Cell CarcinomaStage IV Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Recurrent Head and Neck Squamous Cell Carcinoma+18 more
National Cancer Institute (NCI)158 enrolled176 locationsNCT06589804